IDXX

Idexx Laboratories Inc

676.04

USD

+5.33

+0.79%

Nov 06, 15:59 UTC -5

Closed

After-Market

706.02

+29.99

+4.44%

Idexx Laboratories Inc (IDXX) Earnings

IDXX Earnings Reports

Positive Surprise Ratio

IDXX beat 41 of 43 last estimates.

95%

Next Report

Date of Next Report

Feb 01, 2027

Estimate for Q4 26 (Revenue/ EPS)

$1.20B

$3.46

Implied change from Q3 26 (Revenue/ EPS)

-1.42%

-13.07%

Implied change from Q4 25 (Revenue/ EPS)

+9.76%

+12.34%

Idexx Laboratories Inc earnings per share and revenue

On Nov 02, 2026, IDXX reported earnings of 3.98 USD per share (EPS) for Q3 26, beating the estimate of 3.81 USD, resulting in a 4.41% surprise. Revenue reached 1.21 billion, compared to an expected 1.21 billion, with a -0.04% difference. The market reacted with a +21.85% price change (close before vs. close after earnings).

Looking ahead to Q4 26, -- analysts forecast an EPS of 3.46 USD, with revenue projected to reach 1.20 billion USD, implying an decrease of -13.07% EPS, and decrease of -1.42% in Revenue from the last quarter.

Industry Peers’ Earnings

Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.

GLOBUS MEDICAL INC

Report Date

Nov 05, 2026 For Q3 26

Estimate

$1.22

Actual

$1.23

Surprise

+0.75%

Teleflex Incorporated

Report Date

Nov 05, 2026 For Q3 26

Estimate

$1.92

Actual

$2.63

Surprise

+36.82%

TransMedics Group, Inc. Common Stock

Report Date

Nov 05, 2026 For Q3 26

Estimate

$0.29

Actual

$0.51

Surprise

+71.31%

Tandem Diabetes Care, Inc.

Report Date

Nov 05, 2026 For Q3 26

Estimate

-$0.24

Actual

-$0.10

Surprise

+59.55%

Artivion, Inc.

Report Date

Nov 05, 2026 For Q3 26

Estimate

-$0.06

Actual

$0.08

Surprise

+228.00%

Mobia Medical, Inc. Common Stock

Report Date

Nov 05, 2026 For Q3 26

Estimate

-$0.47

Actual

-$0.52

Surprise

-9.04%

Treace Medical Concepts, Inc. Common Stock

Report Date

Nov 06, 2026 For Q3 26

Estimate

-$0.25

Actual

-$0.19

Surprise

+26.67%

Inogen Inc

Report Date

Nov 05, 2026 For Q3 26

Estimate

-$0.14

Actual

-$0.56

Surprise

-285.41%

Envoy Medical, Inc. Class A Common Stock

Report Date

Nov 05, 2026 For Q3 26

Estimate

-$0.68

Actual

-$0.50

Surprise

+26.47%

CVRx, Inc. Common Stock

Report Date

Nov 05, 2026 For Q3 26

Estimate

-$0.50

Actual

-$0.52

Surprise

-2.91%

FAQ

What were Idexx Laboratories Inc's earnings and revenue for the latest quarter Q3 2026?

For Q3 2026, Idexx Laboratories Inc reported EPS of $3.98, beating estimates by 4.41%, and revenue of $1.21B, -0.04% below expectations.

How did the market react to Idexx Laboratories Inc's Q3 2026 earnings?

The stock price moved up 21.85%, changed from $551.21 before the earnings release to $671.64 the day after.

When is Idexx Laboratories Inc expected to report next?

The next earning report is scheduled for Feb 01, 2027.

What are the forecasts for Idexx Laboratories Inc's next earnings report?

Based on -- analysts, Idexx Laboratories Inc is expected to report EPS of $3.46 and revenue of $1.20B for Q4 2026.

Which companies are reporting earnings today?

Check FXEmpire's Earnings Calendar for today's list of reporting companies.